Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial
Clinical trial NCT04445935 · UNKNOWN
Trial details
- NCT number
- NCT04445935
- Sponsor
- Hamad Medical Corporation
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-28
- Primary completion
- 2020-09-28
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.